BGN Technologies, Ben Gurion University’s technology transfer company, has signed a licensing agreement for its V-Smart drug delivery technology with New York’s Lauren Sciences LLC. Lauren will develop the technology as a platform for treating central nervous system diseases, including Parkinson’s, Alzheimer’s, Amyotrophic Lateral Sclerosis, and brain malignancies. The V-Smart technology pinpoints where the drug will be released in the brain, increasing effectiveness and reducing adverse effects. Lauren was recently awarded a grant from the Michael J. Fox Foundation to develop a V-Smart therapeutic for Parkinson’s disease.
Discover more from
Subscribe to get the latest posts sent to your email.
